Cite

HARVARD Citation

    Kärppä, M. et al. (2020). Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2. Sleep. 43 (9), p. . [Online]. 
  
Back to record